Dr. Kelly E. Faulk
Claim this profileChildren's Hospital Colorado
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Illness
5 reported clinical trials
11 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
KMT2A positive
KMT2A-R positive
KMT2A-R negative
2Illness
KMT2A positive
KMT2A-R positive
KMT2A-R negative
Affiliated Hospitals
Clinical Trials Kelly E. Faulk is currently running
Losartan + Sunitinib
for Osteosarcoma
This trial is testing a combination of two drugs, Losartan and Sunitinib. It aims to find the highest dose that patients can handle without severe side effects. The study will first increase doses to find the limit, then test how well that dose works. Sunitinib has been studied extensively with other drugs for advanced solid tumors, showing varying degrees of success and side effects.
Recruiting1 award Phase 139 criteria
Diagnostic Testing
for Pediatric Leukemia
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
Recruiting1 award Phase 1 & 211 criteria
More about Kelly E. Faulk
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kelly E. Faulk has experience with
- Losartan
- Sunitinib
- Cytarabine
- Fludarabine
- Methotrexate
- Selinexor
Breakdown of trials Kelly E. Faulk has run
T-Lymphoblastic Leukemia/Lymphoma
Illness
Acute Myeloid Leukemia
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelly E. Faulk specialize in?
Kelly E. Faulk focuses on T-Lymphoblastic Leukemia/Lymphoma and Illness. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved KMT2A positive patients, or patients who are KMT2A-R positive.
Is Kelly E. Faulk currently recruiting for clinical trials?
Yes, Kelly E. Faulk is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Kelly E. Faulk has studied deeply?
Yes, Kelly E. Faulk has studied treatments such as Losartan, Sunitinib, Cytarabine.
What is the best way to schedule an appointment with Kelly E. Faulk?
Apply for one of the trials that Kelly E. Faulk is conducting.
What is the office address of Kelly E. Faulk?
The office of Kelly E. Faulk is located at: Children's Hospital Colorado, Aurora, Colorado 80045 United States. This is the address for their practice at the Children's Hospital Colorado.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.